Professional Assessment of the Impact of COVID-19 on Handling NET Patients

Standard

Professional Assessment of the Impact of COVID-19 on Handling NET Patients. / Krug, Sebastian; Garbe, Jakob; König, Senta; Ungewiss, Hanna; Michl, Patrick; Rinke, Anja; Schrader, Jörg.

in: J CLIN MED, Jahrgang 9, Nr. 11, 11.11.2020, S. 3633.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Krug, S, Garbe, J, König, S, Ungewiss, H, Michl, P, Rinke, A & Schrader, J 2020, 'Professional Assessment of the Impact of COVID-19 on Handling NET Patients', J CLIN MED, Jg. 9, Nr. 11, S. 3633. https://doi.org/10.3390/jcm9113633

APA

Krug, S., Garbe, J., König, S., Ungewiss, H., Michl, P., Rinke, A., & Schrader, J. (2020). Professional Assessment of the Impact of COVID-19 on Handling NET Patients. J CLIN MED, 9(11), 3633. https://doi.org/10.3390/jcm9113633

Vancouver

Krug S, Garbe J, König S, Ungewiss H, Michl P, Rinke A et al. Professional Assessment of the Impact of COVID-19 on Handling NET Patients. J CLIN MED. 2020 Nov 11;9(11):3633. https://doi.org/10.3390/jcm9113633

Bibtex

@article{1acb7b7f416c4da3b3ff41fc6fcf7a4c,
title = "Professional Assessment of the Impact of COVID-19 on Handling NET Patients",
abstract = "The treatment and monitoring of patients with neuroendocrine tumors (NET) has been a major challenge during the COVID-19 pandemic. In a survey, we investigated the influence of COVID-19 on the care of NET patients in the German speaking countries Germany, Austria and Switzerland. The multidisciplinarity of all treating physicians in the outpatient and inpatient sector was reflected in our survey. Furthermore, we were able to present findings pertaining to the university and non-university medical care. Overall, only a minority of appointments were cancelled, mostly as a result of medical prioritization and less for fear of infection by patients. In the university sector, longer delays for diagnostic measures were observed in comparison to non-university care. During the COVID-19 crisis, NET patients rarely changed their current therapy, but the pandemic impacted the assessment of the different treatment modalities at risk of developing severe COVID-19 disease. This survey provides the first real-world data on the treatment of NET patients from the physicians' perspective during the COVID-19 crisis. Despite delays in diagnostic procedures and outpatient appointments, only a minority of physicians foresee a major impact of COVID-19 on NET patient care.",
author = "Sebastian Krug and Jakob Garbe and Senta K{\"o}nig and Hanna Ungewiss and Patrick Michl and Anja Rinke and J{\"o}rg Schrader",
year = "2020",
month = nov,
day = "11",
doi = "10.3390/jcm9113633",
language = "English",
volume = "9",
pages = "3633",
journal = "J CLIN MED",
issn = "2077-0383",
publisher = "MDPI AG",
number = "11",

}

RIS

TY - JOUR

T1 - Professional Assessment of the Impact of COVID-19 on Handling NET Patients

AU - Krug, Sebastian

AU - Garbe, Jakob

AU - König, Senta

AU - Ungewiss, Hanna

AU - Michl, Patrick

AU - Rinke, Anja

AU - Schrader, Jörg

PY - 2020/11/11

Y1 - 2020/11/11

N2 - The treatment and monitoring of patients with neuroendocrine tumors (NET) has been a major challenge during the COVID-19 pandemic. In a survey, we investigated the influence of COVID-19 on the care of NET patients in the German speaking countries Germany, Austria and Switzerland. The multidisciplinarity of all treating physicians in the outpatient and inpatient sector was reflected in our survey. Furthermore, we were able to present findings pertaining to the university and non-university medical care. Overall, only a minority of appointments were cancelled, mostly as a result of medical prioritization and less for fear of infection by patients. In the university sector, longer delays for diagnostic measures were observed in comparison to non-university care. During the COVID-19 crisis, NET patients rarely changed their current therapy, but the pandemic impacted the assessment of the different treatment modalities at risk of developing severe COVID-19 disease. This survey provides the first real-world data on the treatment of NET patients from the physicians' perspective during the COVID-19 crisis. Despite delays in diagnostic procedures and outpatient appointments, only a minority of physicians foresee a major impact of COVID-19 on NET patient care.

AB - The treatment and monitoring of patients with neuroendocrine tumors (NET) has been a major challenge during the COVID-19 pandemic. In a survey, we investigated the influence of COVID-19 on the care of NET patients in the German speaking countries Germany, Austria and Switzerland. The multidisciplinarity of all treating physicians in the outpatient and inpatient sector was reflected in our survey. Furthermore, we were able to present findings pertaining to the university and non-university medical care. Overall, only a minority of appointments were cancelled, mostly as a result of medical prioritization and less for fear of infection by patients. In the university sector, longer delays for diagnostic measures were observed in comparison to non-university care. During the COVID-19 crisis, NET patients rarely changed their current therapy, but the pandemic impacted the assessment of the different treatment modalities at risk of developing severe COVID-19 disease. This survey provides the first real-world data on the treatment of NET patients from the physicians' perspective during the COVID-19 crisis. Despite delays in diagnostic procedures and outpatient appointments, only a minority of physicians foresee a major impact of COVID-19 on NET patient care.

U2 - 10.3390/jcm9113633

DO - 10.3390/jcm9113633

M3 - SCORING: Journal article

C2 - 33187393

VL - 9

SP - 3633

JO - J CLIN MED

JF - J CLIN MED

SN - 2077-0383

IS - 11

ER -